InsidersTradesSigma
Track the 나이벡 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 나이벡 has published 1 insider filings. Market capitalisation: €150.4bn. The latest transaction was disclosed on 12 March 2026 (Other). Among the most active insiders: 나이벡. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
나이벡 es una empresa de atención médica y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el tratamiento de enfermedades.